Zhuhai Rundu Pharmaceutical (002923.SZ) announced that the company recently received the National Medical Products Administration's approval and issuance of hydroxy. . . .
Wisdom Financial APP news, Zhuhai Rundu Pharmaceutical (002923.SZ) announced that the company recently received the National Medical Products Administration's approval and issuance of the Hydroxychlorine Sulfate 'Notice of Approval for Market Application of Chemical Raw Materials'. This product is suitable for rheumatoid arthritis, juvenile chronic arthritis, discoid and systemic lupus erythematosus, and skin diseases induced or exacerbated by sunlight.